CPH
Physician Daily · Monday, August 24, 2026
Newsletters Sign in ON AIR
CrosspointHealthNEWS + REFERENCE LIBRARY
Diagnosis Sheet Disruptive, Impulse-Control, and Conduct Disorders DSM-5-TR 312.32 | ICD-10-CM F63.2

Kleptomania

Recurrent failure to resist stealing objects not needed for use or value, driven by rising tension and relief rather than by gain.

Lifetime prevalence~0.3-0.6% (US adults)
Typical onsetLate adolescence to early 20s
Sex ratio~2:1 female:male
CourseChronic, waxing and waning

Clinical picture

  • Theft is impulsive and unplanned, of low-value items the patient can easily afford and then never uses, hoards, discards, returns, or gives away.
  • Mounting tension precedes the act, with pleasure, gratification, or relief at the moment of theft followed rapidly by guilt, shame, and fear of arrest.
  • Patients almost never disclose spontaneously; most surface after arrest, during evaluation for depression, or when a family member forces the issue.
  • Stealing occurs in stores, workplaces, and homes of acquaintances, typically alone, without accomplices, and without preparation or advance planning.
  • Episodes cluster during periods of stress, loss, or depressed mood, and many patients report years of concealed behavior before any clinical contact.
  • Roughly 15 years commonly separate symptom onset from first treatment contact, with legal charges preceding clinical care in most identified cases.

Criteria snapshot

  • Requires repeated inability to resist impulses to steal objects that are not needed for personal use or for their monetary worth.
  • Tension must rise before the theft, with pleasure, gratification, or relief experienced at the time the act is committed.
  • The stealing is not done out of anger or vengeance and is not committed in response to a delusion or a hallucination.
  • The behavior is not better explained by conduct disorder, a manic episode, or antisocial personality disorder.
  • No symptom count or duration threshold applies; diagnosis rests on the impulse-tension-relief pattern and exclusion of ordinary shoplifting for gain.

Neurobiology

  • Opioid-mediated reward signaling is implicated: naltrexone 50-150 mg/day reduced stealing urges versus placebo in a randomized controlled trial.
  • Ventromedial prefrontal and inferior frontal hypofunction on imaging parallels other impulse-control disorders, impairing inhibition and outcome valuation.
  • Diffusion tensor imaging has shown reduced white matter integrity in inferior frontal tracts in kleptomania compared with healthy control subjects.
  • Serotonergic dysregulation is inferred from elevated impulsivity scores and shared familial loading with mood, substance use, and impulse-control disorders.
  • New onset or worsening is reported after traumatic brain injury, frontal or temporal lesions, dementia, and exposure to dopamine agonists.
  • First-degree relatives show elevated rates of alcohol use disorder and mood disorders, suggesting shared reward and impulse-regulation vulnerability.

Psychology

  • Operant conditioning maintains the behavior: the theft terminates aversive tension, making relief a powerful and reliable negative reinforcer.
  • Intermittent thrill and arousal produce highly extinction-resistant responding on a variable schedule, closely paralleling gambling behavior.
  • Cognitive distortions include entitlement after perceived injustice, minimization of harm to large retailers, and the belief that stopping is impossible.
  • Shame and secrecy block disclosure, and patients often present for depression or anxiety without mentioning the stealing unless asked directly.
  • Affect regulation models frame theft as a self-soothing behavior recruited during loneliness, grief, boredom, or interpersonal rejection.

Differential & comorbidity

  • Ordinary shoplifting is planned, motivated by the object's value or by peer influence, and lacks the tension-relief cycle that defines kleptomania.
  • Rule out theft during a manic episode, psychosis-driven stealing, malingering to avoid prosecution, conduct disorder, and antisocial personality disorder.
  • Comorbidity is high: mood disorders in roughly 45-60%, plus anxiety disorders, substance use disorders, and other impulse-control disorders.
  • Suicidal ideation is reported by about a quarter of patients, usually tied to shame over the behavior and to legal or occupational consequences.
  • Screen for bulimia nervosa, which co-occurs at markedly elevated rates, and for compulsive buying and trichotillomania in the same patients.

Pharmacologic treatment

  • No agent is FDA-approved; naltrexone 50-150 mg/day has the best evidence, reducing urge intensity and stealing behavior in a controlled trial.
  • Check baseline and periodic LFTs on naltrexone, confirm the patient is opioid-free for 7 to 10 days, and warn that opioid analgesia will be blocked.
  • SSRIs such as fluoxetine or escitalopram treat comorbid depression and anxiety but have not outperformed placebo for the stealing itself.
  • Topiramate and lithium rest on small open-label series only; reserve them for refractory cases after naltrexone and behavioral treatment fail.
  • Treat comorbid bipolar disorder first, since mood stabilization markedly reduces impulsive theft that occurs inside mood episodes.

Psychotherapy

  • CBT with covert sensitization pairs imagined stealing with aversive imagery such as nausea or arrest, and carries the strongest case-series support.
  • Imaginal desensitization rehearses resisting the urge through to completion and outperformed covert sensitization in small controlled comparisons.
  • Stimulus control restricts solo shopping, enforces cash-only purchases, and avoids high-risk stores during the early months of treatment.
  • Awareness training with competing responses, borrowed from habit reversal, helps patients interrupt the automatic sequence before entering a store.
  • Motivational work is essential, since most patients arrive under legal or family pressure with low intrinsic commitment to changing.

Adjunct options

  • Coordinate with defense counsel and the courts; documented treatment engagement often mitigates sentencing and supports diversion programs.
  • Track urges, near-misses, and episodes in a daily diary; the Kleptomania Symptom Assessment Scale quantifies change across treatment.
  • Involve a partner or family member for accountability, financial oversight, and support after lapses without punitive shaming.
  • Twelve-step and SMART Recovery groups adapted for behavioral addictions supply peer accountability where specialty programs are unavailable.
  • Screen for and treat comorbid eating and substance use disorders, since untreated bulimia or alcohol use predicts relapse into stealing.

Clinical pearls

  • Value of the item is irrelevant; patients steal what they can afford and never use.
  • Naltrexone 50-150 mg/day is the best-supported pharmacotherapy; check LFTs first.
  • Most cases surface only after arrest; ask about stealing directly in mood workups.

References

  • American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.). https://doi.org/10.1176/appi.books.9780890425787
  • Fariba, K. A., & Gokarakonda, S. B. (2023). Impulse control disorders. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK562279/
  • Grant, J. E., Kim, S. W., & Odlaug, B. L. (2009). A double-blind, placebo-controlled study of the opiate antagonist, naltrexone, in the treatment of kleptomania. Biological Psychiatry, 65(7), 600-606. https://doi.org/10.1016/j.biopsych.2008.11.022
  • Grant, J. E., Odlaug, B. L., Davis, A. A., & Kim, S. W. (2009). Legal consequences of kleptomania. Psychiatric Quarterly, 80(4), 251-259. https://doi.org/10.1007/s11126-009-9112-8
  • Grant, J. E., Odlaug, B. L., & Kim, S. W. (2010). Kleptomania: Clinical characteristics and relationship to substance use disorders. The American Journal of Drug and Alcohol Abuse, 36(5), 291-295. https://doi.org/10.3109/00952991003721100
  • Grant, J. E., Potenza, M. N., Weinstein, A., & Gorelick, D. A. (2010). Introduction to behavioral addictions. The American Journal of Drug and Alcohol Abuse, 36(5), 233-241. https://doi.org/10.3109/00952990.2010.491884
  • Sadock, B. J., Sadock, V. A., & Ruiz, P. (2021). Kaplan & Sadock's synopsis of psychiatry (12th ed.). Wolters Kluwer.
  • Stahl, S. M. (2021). Stahl's essential psychopharmacology (5th ed.). Cambridge University Press.